Drug Approval | December 06, 2023
Granules India received ANDA approval for Sildenafil for oral suspension
The current annual U.S. market for Sildenafil for Oral Suspension is approximately $43 million
The current annual U.S. market for Sildenafil for Oral Suspension is approximately $43 million
The product is expected to be launched in FY25
Azelis will be the exclusive distributor for inulin, oligofructose, scFOS, texturized wheat proteins, faba beans, Beta-glucans, meatless solution
Likmez oral suspension is the first and only FDA-approved liquid option for patients with adherence hurdles such as dysphagia, difficulty swallowing
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Evonik China and Shandong Vland Biotech agreed to build a joint venture to expand their presence in gut health solutions products for farm animals globally
Alignment of carbon-fiber can be controlled during the 3D printing process
Expanding to states like Maharashtra, Andhra Pradesh, Telangana, and Manipur while marking the significant milestone in its journey towards providing accessible healthcare services
Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
Subscribe To Our Newsletter & Stay Updated
